Hypertrophic Cardiomyopathy (HCM) in Sphynx Cats
What is HCM?
Hypertrophic Cardiomyopathy (HCM) is the most common heart disease in cats. It occurs when the heart muscle becomes abnormally thickened, which can interfere with the heart’s ability to pump blood effectively. Over time, this can lead to complications such as heart failure, blood clots, or sudden death.
Unfortunately, HCM can develop without any obvious symptoms in the early stages. Many cats appear completely healthy until the disease has already progressed.
Certain breeds, including the Sphynx, are known to have a higher risk of developing HCM.
How common is HCM in Sphynx cats?
Studies have shown that HCM occurs more frequently in Sphynx cats than in the general cat population.
One prospective study of screened Sphynx cats found approximately 40% were diagnosed with HCM by a median age of 5.8 years, indicating a strong breed predisposition.
MDPI +1
For comparison, HCM is estimated to occur in about 15% of the general cat population.
This is why responsible breeders and veterinarians emphasize proactive cardiac screening in this breed.
What causes HCM?
HCM is believed to have a genetic component, but it is not caused by a single gene alone. Research has identified certain genetic variants associated with HCM in Sphynx cats, including variants of the ALMS1 gene, but these do not explain every case of the disease. �
SpringerLink
This means that HCM is likely multifactorial, involving multiple genes and possibly environmental factors. Because of this complexity, even cats from carefully screened lines can still develop the disease
What we do to reduce the risk
At Corbin’s Cathouse, we take HCM screening very seriously. While no breeder can guarantee that HCM will never occur, we believe in doing everything possible to reduce the risk.
Our program includes:
Annual Echocardiograms-
All breeding cats are screened yearly by a board-certified veterinary cardiologist using echocardiography, which is the gold standard for detecting HCM.
Pedigree Tracking-
We carefully research and track pedigrees to monitor heart health in our lines and avoid breeding cats from lines with known cardiac concerns.
Responsible Outcrossing-
Maintaining genetic diversity is extremely important in a relatively small breed population. We work within a trusted breeding circle that supports responsible outcrossing to help maintain healthy genetics.
Genetic Testing-
When applicable, we utilize available genetic testing tools to further evaluate potential risk factors in our breeding cats.
Transparency and reality-
Despite all current screening methods, HCM cannot be completely eliminated at this time. The disease can develop later in life, and even cats with normal scans and clear pedigrees may still develop it.
For this reason, we strongly encourage all Sphynx owners to continue periodic cardiac screening with their veterinarian or cardiologist throughout their cat’s life.
Hope for the future
Research into feline HCM is ongoing. New studies and treatments continue to emerge, including investigations into medications such as rapamycin, which may help slow, treat, or potentially reverse aspects of the disease in some cats.
While research is still developing, these advances give hope that better prevention and treatment options will continue to improve the long-term outlook for the breed.